Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 994 entries
View as:

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT02391259 Org: User:
Start: 11/30/06 End: 11/30/11 Due: 11/30/12

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00125723 Org: User:
Start: 05/31/04 End: 12/31/05 Due: 12/31/06

Long-term Safety Study of Brodalumab in Adults With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01199302 Org: User:
Start: 02/02/11 End: 10/18/11 Due: 10/18/12

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT00148421 Org: User:
Start: - End: - Due: -

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Phase: N/A Priority: Normal
NCT ID: NCT01763866 Org: User:
Start: 01/15/13 End: 12/04/13 Due: 12/04/14

A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04740034 Org: User:
Start: 04/29/21 End: 06/24/24 Due: 06/24/25

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT05909761 Org: User:
Start: 09/16/24 End: 07/31/33 Due: 07/31/34

Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01412957 Org: User:
Start: 11/30/11 End: 11/30/16 Due: 11/30/17

AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

Phase: N/A Priority: Normal
NCT ID: NCT06333951 Org: User:
Start: 09/17/24 End: 10/27/31 Due: 10/27/32

A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT03633708 Org: User:
Start: 04/29/19 End: 01/10/27 Due: 01/10/28

Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05740566 Org: User:
Start: 05/31/23 End: 03/26/28 Due: 03/26/29

Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT01583374 Org: User:
Start: 05/02/12 End: 10/25/18 Due: 10/25/19

Single Ascending Dose Study of AMG 570 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02618967 Org: User:
Start: 03/28/16 End: 12/03/18 Due: 12/03/19

A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT00936988 Org: User:
Start: 11/30/00 End: 12/31/05 Due: 12/31/06

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

Phase: N/A Priority: Normal
NCT ID: NCT06211036 Org: User:
Start: 06/05/24 End: 07/31/28 Due: 07/31/29

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03937154 Org: User:
Start: 02/26/20 End: 05/20/27 Due: 05/20/28

An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00111111 Org: User:
Start: - End: - Due: -

Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)

Phase: N/A Priority: Normal
NCT ID: NCT01313208 Org: User:
Start: 03/31/11 End: 05/31/13 Due: 05/31/14

Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin

Phase: N/A Priority: Normal
NCT ID: NCT06207682 Org: User:
Start: 06/28/22 End: 08/11/22 Due: 08/11/23

Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT04680637 Org: User:
Start: 05/06/21 End: 05/22/23 Due: 05/22/24

Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab

Phase: N/A Priority: Normal
NCT ID: NCT01927757 Org: User:
Start: 05/06/13 End: 06/11/15 Due: 06/11/16

Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)

Phase: N/A Priority: Normal
NCT ID: NCT02624869 Org: User:
Start: 09/10/16 End: 06/01/21 Due: 06/01/22

Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China

Phase: N/A Priority: Normal
NCT ID: NCT06332014 Org: User:
Start: 08/06/24 End: 08/04/26 Due: 08/04/27

A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

Phase: N/A Priority: Normal
NCT ID: NCT06588153 Org: User:
Start: 05/24/25 End: 05/24/27 Due: 05/24/28

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Phase: N/A Priority: Normal
NCT ID: NCT00925600 Org: User:
Start: 11/30/09 End: 05/12/16 Due: 05/12/17